Literature DB >> 25121755

The effect of orthostatic stress type on cardiovascular control.

Brett H Shaw1, Thomas M Loughin, Dawn C Mackey, Stephen N Robinovitch, Victoria E Claydon.   

Abstract

OBJECTIVES: We aimed to compare the cardiovascular responses of a novel orthostatic stress test, the passive seated orthostatic stress test (PSOST), with those during passive head-up tilt testing (HUTT). We hypothesized that cardiovascular responses during PSOST would be similar to those during HUTT (the 'gold standard').
METHODS: We tested 15 healthy volunteers, who underwent both PSOST and HUTT during one session in a random order. We measured beat-to-beat blood pressure, heart rate, peripheral resistance, stroke volume, cardiac output, and middle cerebral artery blood flow velocity during each test.
RESULTS: Blood pressure responses were not significantly different between PSOST and HUTT, except for a significantly lower delayed nadir and 15-min recovery value in systolic arterial pressure during HUTT. HUTT elicited a significantly larger increase in heart rate during all test intervals in comparison with PSOST, as well as a larger decline in stroke volume during almost all test intervals. Responses for the other hemodynamic variables were not significantly different between the tests at any test interval. Repeated HUTT has large inherent variability, which was also evident from the variability in the mean differences on comparing PSOST and HUTT. There was a significant bias for larger heart rate increases (P<0.01) and a greater delayed systolic arterial pressure decline during HUTT.
CONCLUSION: We have shown that PSOST and HUTT elicit similar blood pressure and cerebrovascular responses in the early stages of the upright phase. We believe that PSOST is a reasonable surrogate for HUTT in assessing orthostatic hypotension in population groups that are unable to stand for prolonged periods of time.

Entities:  

Mesh:

Year:  2014        PMID: 25121755     DOI: 10.1097/MBP.0000000000000067

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  5 in total

1.  Relationships between orthostatic hypotension, frailty, falling and mortality in elderly care home residents.

Authors:  Brett H Shaw; Dave Borrel; Kimiya Sabbaghan; Colton Kum; Yijian Yang; Stephen N Robinovitch; Victoria E Claydon
Journal:  BMC Geriatr       Date:  2019-03-13       Impact factor: 3.921

2.  Prognostic value of postural hypotension in hospitalized patients with heart failure.

Authors:  Tsutomu Sunayama; Daichi Maeda; Yuya Matsue; Nobuyuki Kagiyama; Kentaro Jujo; Kazuya Saito; Kentaro Kamiya; Hiroshi Saito; Yuki Ogasawara; Emi Maekawa; Masaaki Konishi; Takeshi Kitai; Kentaro Iwata; Hiroshi Wada; Masaru Hiki; Taishi Dotare; Takatoshi Kasai; Hirofumi Nagamatsu; Tetsuya Ozawa; Katsuya Izawa; Shuhei Yamamoto; Naoki Aizawa; Ryusuke Yonezawa; Kazuhiro Oka; Shin-Ichi Momomura; Tohru Minamino
Journal:  Sci Rep       Date:  2022-02-18       Impact factor: 4.379

3.  Cardiovascular responses to orthostasis and their association with falls in older adults.

Authors:  Brett H Shaw; Thomas M Loughin; Stephen N Robinovitch; Victoria E Claydon
Journal:  BMC Geriatr       Date:  2015-12-24       Impact factor: 3.921

4.  Sitting-induced hemodynamic changes and association with sitting intolerance in children and adolescents: a cross-sectional study.

Authors:  Chunyan Tao; Zhenhui Han; Yongqiang Yan; Zhitao Pan; Hanwen Zhu; Xueying Li; Hongxia Li; Yuanyuan Wang; Ping Liu; Yuli Wang; Min Jiang; Chaoshu Tang; Hongfang Jin; Junbao Du
Journal:  Sci Rep       Date:  2020-08-18       Impact factor: 4.379

5.  Heart rate and blood pressure response improve the prediction of orthostatic cardiovascular dysregulation in persons with chronic spinal cord injury.

Authors:  Siqi Wang; Jill M Wecht; Bonnie Legg Ditterline; Beatrice Ugiliweneza; Matthew T Maher; Alexander T Lombard; Sevda C Aslan; Alexander V Ovechkin; Brielle Bethke; Jordan T H Gunter; Susan J Harkema
Journal:  Physiol Rep       Date:  2020-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.